Pipeline
Zacharon is using an innovative drug discovery and development platform to create first-in-class small molecule drugs targeting glycans. Our programs target multiple forms of lysosomal storage disease and rare forms of cancer, diseases with substantial morbidity and mortality and few, if any, existing treatment options.
